Rett ST
RS Study
Is your child living with Rett Syndrome and experiencing breathing abnormalities? Newron Pharmaceuticals are conducting a research trial to evaluate the safety, tolerability and efficacy of Sarizotan in reducing respiratory abnormalities in patients with Rett Syndrome Patients who are 13 years and older and have a body weight of 25 kg or over may be eligible. The study is being conducted at the location below. If you are interested to learn more about this study, please contact the site. London: Department of Child and Adolescent Psychiatry, PO86, Institute of Psychiatry, Psychology and Neuroscience, 16 De Crespigny Park, London, SE5 8AF Daytime Telephone Number(s): 0207 848 0690 (KCL) 020 3228 3995/3900 (Team Administrator, SLaM)
Principal Investigator: Dr Paramala J Santosh
Sarizotan/001/II/2015 Newron STARS – Flyer_UK, Version 1, 01 Dec 2016